HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Fujii Selected Research

FR234938

3/2006Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Fujii Research Topics

Disease

18Neoplasms (Cancer)
01/2021 - 07/2002
12Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 06/2006
9Infections
06/2022 - 02/2009
9Aneurysm (Aneurysms)
01/2022 - 02/2008
7Squamous Cell Carcinoma of Head and Neck
01/2022 - 03/2008
6Intracranial Aneurysm (Cerebral Aneurysm)
02/2022 - 10/2018
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 02/2007
5Hypopharyngeal Neoplasms
05/2019 - 10/2010
5Pathologic Constriction (Stenosis)
11/2018 - 04/2004
4Thrombosis (Thrombus)
02/2022 - 10/2020
4Tongue Neoplasms (Tongue Neoplasm)
01/2021 - 07/2014
4Neoplasm Metastasis (Metastasis)
01/2021 - 08/2005
4Inflammation (Inflammations)
02/2020 - 03/2006
4Schizophrenia (Dementia Praecox)
01/2017 - 01/2011
4Hepatocellular Carcinoma (Hepatoma)
06/2004 - 04/2004
3Hemorrhage
06/2022 - 05/2011
3Deglutition Disorders (Dysphagia)
09/2021 - 02/2017
3Respiratory Insufficiency (Respiratory Failure)
12/2020 - 09/2012
3Atrial Fibrillation
12/2020 - 01/2014
3Multi-centric Castleman's Disease
12/2018 - 02/2003
3Major Depressive Disorder (Major Depressive Disorders)
09/2014 - 11/2011
3Lymphoma (Lymphomas)
12/2012 - 06/2003
3Hypertension (High Blood Pressure)
01/2010 - 09/2002
2Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2017
2Acute Coronary Syndrome
01/2021 - 02/2008
2Aspiration Pneumonia
10/2020 - 12/2018
2Hematoma
05/2019 - 12/2017
2Thrombocytopenia (Thrombopenia)
12/2018 - 02/2014
2Renal Insufficiency (Renal Failure)
12/2018 - 06/2003
2Cerebral Hemorrhage
12/2018 - 01/2013
2Fever (Fevers)
12/2018 - 01/2018
2Lymphatic Metastasis
12/2015 - 02/2010
2Esophageal Neoplasms (Esophageal Cancer)
04/2015 - 09/2012
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2015 - 01/2009
2Apnea
10/2014 - 09/2012
2Chronic Obstructive Pulmonary Disease (COPD)
10/2014 - 09/2012
2Hypoventilation
10/2014 - 09/2012
2Proteinuria
02/2014 - 06/2003
2Albuminuria
12/2012 - 02/2007
2Melanoma (Melanoma, Malignant)
01/2011 - 09/2009
2Chronic Renal Insufficiency
03/2008 - 02/2007
2Lung Neoplasms (Lung Cancer)
02/2007 - 10/2005
2Essential Hypertension
02/2007 - 09/2002
2Hypersensitivity (Allergy)
03/2006 - 02/2003
2Type 2 Diabetes Mellitus (MODY)
10/2005 - 10/2005
2Atherosclerotic Plaque (Atheroma)
06/2005 - 07/2002
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2004 - 10/2002
2Myocardial Infarction
11/2004 - 04/2004
2Rheumatoid Arthritis
08/2003 - 07/2003
1Seizures (Absence Seizure)
06/2022
1Epileptic Syndromes
06/2022
1Glioblastoma (Glioblastoma Multiforme)
11/2021
1Oropharyngeal Neoplasms
09/2021

Drug/Important Bio-Agent (IBA)

5NivolumabIBA
01/2022 - 03/2021
5Proteins (Proteins, Gene)FDA Link
03/2017 - 06/2003
5LipidsIBA
01/2013 - 07/2002
5CholesterolIBA
06/2004 - 05/2002
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 09/2012
3AnticoagulantsIBA
10/2020 - 01/2014
3Interleukin-6 (Interleukin 6)IBA
12/2018 - 02/2003
3Phenobarbital (Luminal)FDA Link
09/2018 - 10/2005
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2019
2GlucocorticoidsIBA
02/2020 - 12/2018
2Immunoglobulin G (IgG)IBA
12/2018 - 02/2014
2Hemoglobins (Hemoglobin)IBA
02/2017 - 10/2012
2Immunosuppressive Agents (Immunosuppressants)IBA
09/2015 - 02/2003
2Prednisolone (Predate)FDA LinkGeneric
09/2015 - 04/2015
2apixabanIBA
01/2015 - 01/2014
2Indicators and Reagents (Reagents)IBA
01/2014 - 10/2012
2CreatinineIBA
12/2012 - 03/2008
2AlbuminsIBA
12/2012 - 09/2002
2Serum AlbuminIBA
10/2012 - 06/2003
2Monophenol Monooxygenase (Tyrosinase)IBA
01/2011 - 09/2009
2Ethanol (Ethyl Alcohol)IBA
01/2011 - 10/2006
2Anesthetics (Anesthetic Agents)IBA
08/2010 - 10/2005
2SodiumIBA
02/2007 - 09/2002
2Thallium-201IBA
05/2006 - 09/2005
2Triglycerides (Triacylglycerol)IBA
10/2005 - 10/2005
2FR177391IBA
10/2005 - 10/2005
2LDL Receptors (LDL Receptor)IBA
06/2004 - 04/2004
2FR171456IBA
04/2004 - 04/2004
1NimustineIBA
11/2021
1Lomustine (CCNU)FDA Link
11/2021
1Temozolomide (Temodar)FDA LinkGeneric
11/2021
1Cetuximab (Erbitux)FDA Link
06/2021

Therapy/Procedure

26Radiotherapy
06/2022 - 07/2002
22Therapeutics
06/2022 - 07/2002
9Drug Therapy (Chemotherapy)
01/2022 - 09/2012
8Stents
02/2022 - 05/2002
7Neck Dissection (Radical Neck Dissection)
06/2021 - 06/2006
6Chemoradiotherapy
01/2022 - 09/2012
3Aftercare (After-Treatment)
04/2021 - 10/2010
3Catheters
11/2018 - 06/2005
3Craniotomy
10/2018 - 10/2017
3Percutaneous Coronary Intervention
02/2008 - 04/2004
2Adjuvant Radiotherapy
09/2021 - 08/2017
2Lymph Node Excision (Lymph Node Dissection)
05/2019 - 12/2015
2Operative Surgical Procedures
01/2017 - 08/2014
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
10/2014 - 09/2012
1Critical Care (Surgical Intensive Care)
06/2022